This week's FierceBiotech is brought to you by Novella.
Main Banner
Button
Embracing Innovative Designs in Early Phase Oncology Studies
 
Scientific advancements combined with unmet patient needs are driving accelerated timelines and creative pathways for oncology drug development. This complimentary white paper explores protocol design considerations to help you choose the best clinical trial strategy. Novella Clinical provides sponsors with these insights:
  • Review the genesis of the clinical development process savings
  • Understand how seamless oncology clinical trial strategy differs from traditional pathways
  • Explore alternate clinical trial routes during early phase design to potentially accelerate approval
Novella Clinical, a Quintiles company, is a full-service clinical research organization specializing in supporting small to mid-sized oncology companies. Visit your global oncology CRO at NovellaClinical.com/Oncology-Trials

Global Headquarters: 1700 Perimeter Park Drive, Morrisville, NC 27560, USA | Phone: +1-919-484-1921
European Operations: Abel Smith House, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2ST, UK | Phone: +44 (0) 1438 221122

Want to reach 150,000+ FierceBiotech subscribers with your own message?
Contact aalcover@fiercemarkets.com or call 202-824-5074.



About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech.
Click here to unsubscribe.

FierceMarkets, a division of Questex, LLC
1900 L St. NW Suite 400 
Washington, DC 20036
.